tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Tightens Shareholder Structure with Targeted Buyback

Story Highlights
  • EKF Diagnostics repurchased 200,000 shares into treasury, leaving 433.2 million voting shares outstanding.
  • Buyback included 59,000 shares from Harwood-managed funds, keeping director Christopher Mills’ stake near 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Tightens Shareholder Structure with Targeted Buyback

Claim 70% Off TipRanks Premium

EKF Diagnostics Holdings ( (GB:EKF) ) just unveiled an update.

EKF Diagnostics Holdings has repurchased 200,000 of its ordinary shares at a weighted average price of 25.989p per share, placing the stock in treasury and leaving 433,218,112 shares in issue with voting rights out of a total issued share capital of 435,383,092. As part of this buyback, the company acquired 59,000 shares from funds managed by Harwood, ensuring that non-executive director Christopher Mills’ aggregate indirect stake remains at roughly 30% of voting rights, a move that fine-tunes the shareholder structure while supporting capital management objectives and maintaining regulatory thresholds for major shareholdings.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics company focused on point-of-care analysers in hematology and diabetes, as well as life sciences services involving the specialist manufacture of enzymes and custom products used in diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the group operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 473,311

Technical Sentiment Signal: Strong Sell

Current Market Cap: £112.8M

See more insights into EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1